• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » UK government creates working group to improve research transparency

UK government creates working group to improve research transparency

September 15, 2011
CenterWatch Staff

With momentum building for open-access publishing and debate continuing to rage about access to clinical trial data, the UK government is setting up an independent working group to look at how UK-funded research findings can be made more widely available, according to PharmaTimes.

The working group, to be chaired by Dame Janet Finch, professor of sociology at Manchester University and independent co-chair of the Council for Science and Technology, will examine how access to research findings can be made more transparent and accessible, taking into account a range of considerations including parallel work on research data and other outputs being conducted by the Royal Society.

The focus will be on academic publications, specifically journal articles, conference proceedings and monographs. The group’s work will be supported by the Department for Business, Innovation and Skills, the Higher Education Funding Council for England, the Publishers Association and Research Councils UK. The Research Information Network will provide the group’s secretariat.

The new working group will hold its first meeting in mid-October and aims to come up with recommendations to government in the spring of 2012. Other than Dame Janet, the membership will include representatives from the higher education sector, research investors, the research community, scholarly publishers and libraries.

“Transparency is at the heart of the government’s agenda and it should apply to published research,” Willetts said. “We do fantastic research in the UK, of which we can be rightly proud, but I want to ensure that people are given the opportunity to know more about the projects that government funds.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing